Available Brands
Did you find this information helpful?
Author Details

Written By
P. Thirumal Reddy
B. Pharm

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 18 Dec 2023 | 03:18 PM (IST)

Want to know more?
Read Our Editorial Policy
Quick Summary
LOSARTAN
Last updated on 18 Dec 2023 | 03:18 PM (IST)
LOSARTAN
Background and Date of approval LOSARTAN
Losartan was first approved by the U.S. Food and Drug Administration (FDA) in 1995 for treating hypertension and is scheduled for generic release in April 2010.
Uses of LOSARTAN
Losartan helps to treat hypertension (high blood pressure) and diabetic nephropathy and is used to prevent heart failure and stroke.
How is LOSARTAN administered?
Losartan is available as a tablet with 25mg, 50 mg, and 100 mg. The usual starting dose of Losartan is 50 mg once daily. Take this medication with or without food. Avoid crushing or chewing instead of swallowing it whole.
Side Effects of LOSARTAN
The side effects known to occur commonly during the treatment with Losartan are dizziness, anemia (lack of blood), hyperkalemia (high potassium levels in the blood), orthostatic hypotension (low blood pressure when standing), renal impairment and failure, hypoglycemia (low blood sugar), upper respiratory tract infection, nasal decongestant, back pain, and cough. If you experience severe allergic reactions or heart, liver, and kidney problems, report your physician immediately.
Warnings
Inform your doctor immediately if you experience allergies to Losartan and its ingredients. Notify your healthcare provider if you are vomiting or having diarrhea. Tell your doctor before the treatment commencement if you are pregnant or having liver, kidney, or heart problems. You might require regular blood pressure monitoring while taking Losartan to avoid fluctuations.
Precautions
Consult your doctor before using this medication if you are pregnant or plan to have a baby. Discontinue Losartan as soon as possible as it may affect the renin-angiotensin system during the second and third trimesters of pregnancy and can reduce fetal renal dysfunction and even the death of the unborn baby. Avoid breastfeeding your baby while on the medicine as it is unknown if Losartan passes into the breast milk.
Word of Advice
Losartan is not recommended for pediatric patients below six years. Monitor renal function and serum potassium periodically as it helps to treat renal impairment and hyperkalemia. It is advised to patients receiving Losartan not to use potassium supplements without consulting their healthcare provider. Losartan is recommended along with a low-salt diet and regular exercise for beneficial results. Driving or using machinery should be avoided if you feel dizzy, tired, or sleepy.
Frequently Asked Questions
Q1.
What is Losartan used for?
Losartan helps to prevent heart failure and stroke and is used to treat hypertension (high blood pressure) and diabetic nephropathy.
Q2.
What are the most common side effects of Losartan?
The most common side effects of Losartan are dizziness, anemia (lack of blood), hyperkalemia (high potassium levels in the blood), orthostatic hypotension (low blood pressure when standing), renal impairment and failure, hypoglycemia (low blood sugar), back pain and cough.
Q3.
Is Losartan safe during pregnancy?
No, Losartan is unsafe to use during pregnancy as it affects the renin-angiotensin system and can reduce fetal renal dysfunction and even the death of the unborn baby.
Q4.
Is Losartan safe for diabetic patients?
Losartan may be safe for diabetic patients if prescribed by a doctor. This medication protects kidneys and decreases kidney function in hypertensive (high blood pressure) and type 2 diabetic patients.
Q5.
Do potassium supplements be taken with Losartan?
No, taking potassium supplements with Losartan is not recommended as it may increase potassium levels in the blood (hyperkalemia). Please check your doctor before using any other medications with Losartan.
References
- Edward Chu, Lange’s Basic and clinical pharmacology, Angiotensin receptor blocking agents,14th Edition, 2018, 203-207.
- Accord-UK Ltd.., Electronic Medicines Compendium (EMC), [Revised on March 2019] [Accessed on 2nd September 2022] https://www.medicines.org.uk/emc/product/5875/smpc#
- Merck & co Inc., US Food & Drug Administration, [Revised on Oct 2018] [Accessed on 2nd September 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020386s062lbl.pdf
- Swiss Garnier Life Sciences [Accessed on 2nd September 2022]https://biocon.com/docs/prescribing_information/cardiology/zargo_pi.pdf
Disclaimer
The drug information on this page is not a substitute for medical advice; it is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you are eligible to receive this treatment.






